Markers of bone and mineral metabolism are shown in Figure 2B. Similar to CKD patients, the adenine group developed a significant hyperphosphatemia, secondary hyperparathyroidism and severely elevated FGF23 paralleled by an increased urinary excretion of phosphorous [13]. The gene discussed is FGF23; the disease is chronic kidney disease.